Admedus releases new CardioCel scaffold in U.S.

Admedus announces the U.S. launch of a new version of its CardioCel regenerative bioscaffold for vascular repair.

Admedus (ASX:AHZ) announced the U.S. launch of a new CardioCel bioscaffold designed for vascular repairs.

Admedus Ltd.

News Well, Regenerative Medicine, Vascular

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1FjQZ9h